Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

PLANET GREEN HOLDINGS CORP Current Ratio 2006-2020 | PLAG

PLANET GREEN HOLDINGS CORP current ratio from 2006 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
PLANET GREEN HOLDINGS CORP Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-06-30 $0.02B $0.00B 5.83
2020-03-31 $0.02B $0.00B 6.33
2019-12-31 $0.02B $0.01B 3.79
2019-09-30 $0.02B $0.01B 2.07
2019-06-30 $0.02B $0.01B 2.28
2019-03-31 $0.01B $0.01B 2.11
2018-12-31 $0.02B $0.01B 1.51
2018-09-30 $0.02B $0.01B 1.73
2018-06-30 $0.02B $0.08B 0.25
2018-03-31 $0.02B $0.08B 0.23
2017-12-31 $0.02B $0.08B 0.21
2017-09-30 $0.05B $0.08B 0.60
2017-06-30 $0.05B $0.09B 0.58
2017-03-31 $0.05B $0.09B 0.60
2016-12-31 $0.07B $0.08B 0.81
2016-09-30 $0.18B $0.08B 2.27
2016-06-30 $0.18B $0.08B 2.34
2016-03-31 $0.18B $0.07B 2.74
2015-12-31 $0.19B $0.10B 1.97
2015-09-30 $0.20B $0.11B 1.87
2015-06-30 $0.20B $0.10B 1.93
2015-03-31 $0.20B $0.10B 1.89
2014-12-31 $0.20B $0.09B 2.21
2014-09-30 $0.23B $0.10B 2.22
2014-06-30 $0.20B $0.06B 3.19
2014-03-31 $0.19B $0.06B 3.42
2013-12-31 $0.19B $0.05B 4.03
2013-09-30 $0.18B $0.05B 3.80
2013-06-30 $0.17B $0.05B 3.48
2013-03-31 $0.16B $0.04B 3.81
2012-12-31 $0.16B $0.04B 3.76
2012-09-30 $0.16B $0.06B 2.69
2012-06-30 $0.13B $0.04B 3.59
2012-03-31 $0.13B $0.04B 3.17
2011-12-31 $0.13B $0.05B 2.78
2011-09-30 $0.11B $0.03B 4.35
2011-06-30 $0.10B $0.03B 3.68
2011-03-31 $0.10B $0.03B 3.20
2010-12-31 $0.10B $0.04B 2.41
2010-09-30 $0.11B $0.06B 2.05
2010-06-30 $0.09B $0.05B 1.96
2010-03-31 $0.10B $0.05B 2.10
2009-12-31 $0.10B $0.05B 2.07
2009-09-30 $0.08B $0.04B 1.77
2009-06-30 $0.07B $0.05B 1.65
2009-03-31 $0.07B $0.05B 1.57
2008-12-31 $0.06B $0.04B 1.60
2008-09-30 $0.07B $0.05B 1.54
2008-06-30 $0.07B $0.04B 1.51
2008-03-31 $0.06B $0.04B 1.44
2007-12-31 $0.07B $0.05B 1.41
2007-09-30 $0.06B $0.04B 1.50
2007-06-30 $0.05B $0.03B 1.68
2007-03-31 $0.00B $0.00B 0.03
2006-12-31 $0.04B $0.03B 1.10
2006-09-30 $0.00B $0.00B 0.00
2006-06-30 $0.00B $0.00B 0.15
2006-03-31 $0.00B $0.00B 0.45
2005-12-31 $0.00B $0.00B 0.10
2005-09-30 $0.00B $0.00B 0.30
2005-06-30 $0.00B $0.00B 0.40
2005-03-31 $0.00B $0.00B 0.50
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.020B $0.004B
Planet Green Holdings Corp is a biotechnology enterprise. It provides artificial intelligence integrates extraction, R&D, production and sales from natural plants. Planet Green Holdings Corp., formerly known as American Lorain Corporation, is based in China.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $144.959B 15.74
Bristol Myers Squibb (BMY) United States $132.956B 10.24
CSL (CSLLY) Australia $94.659B 0.00
Gilead Sciences (GILD) United States $79.486B 11.44
Vertex Pharmaceuticals (VRTX) United States $69.696B 38.89
Regeneron Pharmaceuticals (REGN) United States $60.804B 23.25
Biogen (BIIB) United States $43.182B 7.39
Illumina (ILMN) United States $39.202B 45.59
Seattle Genetics (SGEN) United States $31.659B 0.00
Moderna (MRNA) United States $27.116B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.098B 10.46
Genmab (GMAB) Denmark $24.986B 15.78
BeiGene (BGNE) Cayman Islands $24.300B 0.00
Genmab (GNMSF) Denmark $23.331B 5.37
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $21.904B 0.00
Immunomedics (IMMU) United States $19.659B 0.00
Incyte (INCY) United States $19.012B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.137B 37.76
Alnylam Pharmaceuticals (ALNY) United States $15.498B 0.00
BioNTech SE (BNTX) Germany $15.171B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.077B 68.19
BioMarin Pharmaceutical (BMRN) United States $14.392B 104.42
Sarepta Therapeutics (SRPT) United States $11.486B 0.00
QIAGEN (QGEN) Netherlands $11.467B 29.10
ARGENX SE-ADR (ARGX) Netherlands $11.417B 0.00
Exact Sciences (EXAS) United States $10.950B 0.00
Guardant Health (GH) United States $10.705B 0.00
Bio-Techne Corp (TECH) United States $9.378B 64.35
Galapagos (GLPG) Belgium $8.968B 32.49
Exelixis (EXEL) United States $7.913B 28.77
SWEDISH ORP BIO (BIOVF) Sweden $7.814B 19.44
Ascendis Pharma (ASND) Denmark $7.624B 0.00
Repligen (RGEN) United States $7.558B 119.97
Mirati Therapeutics (MRTX) United States $7.295B 0.00
MyoKardia (MYOK) United States $7.029B 0.00
Novavax (NVAX) United States $6.840B 0.00
Acceleron Pharma (XLRN) United States $6.553B 0.00
Adaptive Biotechnologies (ADPT) United States $6.528B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.460B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.232B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.232B 193.07
Emergent Biosolutions (EBS) United States $5.332B 21.12
Ultragenyx Pharmaceutical (RARE) United States $5.017B 0.00
Blueprint Medicines (BPMC) United States $4.824B 0.00
Zai Lab (ZLAB) China $4.418B 0.00
China Biologic Products (CBPO) China $4.355B 25.85
MorphoSys AG (MOR) Germany $4.263B 55.86
Arena Pharmaceuticals (ARNA) United States $4.256B 0.00
Vir Biotechnology (VIR) United States $4.179B 0.00
NeoGenomics (NEO) United States $3.966B 1197.00
Denali Therapeutics (DNLI) United States $3.802B 0.00
Legend Biotech (LEGN) United States $3.773B 0.00
Reata Pharmaceuticals (RETA) United States $3.734B 0.00
Bluebird Bio (BLUE) United States $3.681B 0.00
Halozyme Therapeutics (HALO) United States $3.646B 0.00
Amicus Therapeutics (FOLD) United States $3.569B 0.00
Insmed (INSM) United States $3.369B 0.00
Principia Biopharma (PRNB) United States $3.321B 0.00
Global Blood Therapeutics (GBT) United States $3.287B 0.00
Fate Therapeutics (FATE) United States $3.221B 0.00
Twist Bioscience (TWST) United States $2.980B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.932B 0.00
Inovio Pharmaceuticals (INO) United States $2.845B 0.00
Alkermes (ALKS) Ireland $2.729B 57.20
Sorrento Therapeutics (SRNE) United States $2.609B 0.00
PHARMA MAR SA (PHMMF) Spain $2.290B 0.00
I-Mab (IMAB) China $2.254B 0.00
Mesoblast (MESO) Australia $2.128B 0.00
Editas Medicine (EDIT) United States $2.040B 0.00
Seres Therapeutics (MCRB) United States $2.020B 0.00
Zymeworks (ZYME) Canada $2.007B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.006B 22.47
Intra-Cellular Therapies (ITCI) United States $1.912B 0.00
Akcea Therapeutics (AKCA) United States $1.843B 0.00
Revance Therapeutics (RVNC) United States $1.809B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.801B 0.00
UniQure (QURE) Netherlands $1.780B 0.00
Eidos Therapeutics (EIDX) United States $1.743B 0.00
Amarin (AMRN) Ireland $1.484B 0.00
Sangamo Therapeutics (SGMO) United States $1.482B 0.00
Viela Bio (VIE) United States $1.475B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.465B 0.00
Cytokineticsorporated (CYTK) United States $1.451B 0.00
Ligand Pharmaceuticals (LGND) United States $1.440B 48.67
Beam Therapeutics (BEAM) United States $1.438B 0.00
Zealand Pharma (ZEAL) Denmark $1.433B 0.00
Mersana Therapeutics (MRSN) United States $1.427B 0.00
Coherus BioSciences (CHRS) United States $1.345B 7.84
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
Intellia Therapeutics (NTLA) United States $1.326B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.308B 0.00
Epizyme (EPZM) United States $1.285B 0.00
Arcus Biosciences (RCUS) United States $1.214B 0.00
Compugen (CGEN) Israel $1.208B 0.00
NGM Biopharmaceuticals (NGM) United States $1.152B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.133B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.091B 0.00
REGENXBIO (RGNX) United States $1.079B 0.00
Athenex (ATNX) United States $1.049B 0.00
Arvinas (ARVN) United States $1.027B 0.00
Castle Biosciences (CSTL) United States $1.012B 0.00
Alcobra (ARCT) United States $1.003B 0.00
Alector (ALEC) United States $0.985B 0.00
Adverum Biotechnologies (ADVM) United States $0.957B 0.00
Retrophin (RTRX) United States $0.953B 0.00
Myriad Genetics (MYGN) United States $0.946B 0.00
Heska (HSKA) United States $0.923B 0.00
Vericel (VCEL) United States $0.856B 0.00
NantKwest (NK) United States $0.836B 0.00
Pliant Therapeutics (PLRX) United States $0.834B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.832B 0.00
Morphic Holding (MORF) United States $0.819B 0.00
Cellectis S.A (CLLS) France $0.811B 0.00
Protagonist Therapeutics (PTGX) United States $0.780B 0.00
Agenus (AGEN) United States $0.776B 0.00
VBI Vaccines (VBIV) United States $0.758B 0.00
Frequency Therapeutics (FREQ) United States $0.756B 0.00
Kadmon Holdings (KDMN) United States $0.726B 0.00
Intrexon (PGEN) United States $0.715B 0.00
Pharming Group (PHGUF) Netherlands $0.714B 16.29
Codexis (CDXS) United States $0.708B 0.00
MiMedx (MDXG) United States $0.693B 0.00
Northwest Biotherapeutics (NWBO) United States $0.681B 0.00
Cara Therapeutics (CARA) United States $0.664B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
AC Immune SA (ACIU) Switzerland $0.626B 0.00
Clovis Oncology (CLVS) United States $0.614B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.598B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
WAVE Life Sciences (WVE) Singapore $0.577B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.565B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.564B 0.00
Geron (GERN) United States $0.559B 0.00
Scholar Rock Holding (SRRK) United States $0.540B 0.00
Albireo Pharma (ALBO) United States $0.540B 0.00
Dynavax Technologies (DVAX) United States $0.539B 0.00
Cel-Sci (CVM) United States $0.518B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.514B 4.50
IVERIC Bio (ISEE) United States $0.512B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.494B 0.00
Celldex Therapeutics (CLDX) United States $0.487B 0.00
Forte Biosciences (FBRX) United States $0.482B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.478B 0.00
Cue Biopharma (CUE) United States $0.477B 0.00
MeiraGTx Holdings (MGTX) United States $0.477B 0.00
Anika Therapeutics (ANIK) United States $0.474B 20.73
Kala Pharmaceuticals (KALA) United States $0.469B 0.00
Syros Pharmaceuticals (SYRS) United States $0.453B 0.00
MannKind (MNKD) United States $0.442B 0.00
Pfenex (PFNX) United States $0.441B 0.00
Starpharma Holdings (SPHRY) Australia $0.436B 0.00
AnaptysBio (ANAB) United States $0.430B 0.00
UROGEN PHARMA (URGN) United States $0.429B 0.00
Avid Bioservices (CDMO) United States $0.421B 0.00
Amryt Pharma (AMYT) United Kingdom $0.412B 0.00
Prothena (PRTA) Ireland $0.411B 0.00
Puma Biotechnology (PBYI) United States $0.404B 0.00
IBio (IBIO) United States $0.396B 0.00
Sutro Biopharma (STRO) United States $0.395B 0.00
BioDelivery Sciences (BDSI) United States $0.393B 27.79
Athersys (ATHX) United States $0.389B 0.00
Kamada (KMDA) Israel $0.387B 18.49
Xenon Pharmaceuticals (XENE) Canada $0.387B 0.00
Fortress Biotech (FBIO) United States $0.385B 0.00
Trevena (TRVN) United States $0.376B 0.00
Cellular Biomedicine (CBMG) United States $0.361B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.354B 0.00
PDL BioPharma (PDLI) United States $0.351B 0.00
ANI Pharmaceuticals (ANIP) United States $0.348B 8.22
Merus (MRUS) Netherlands $0.348B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.322B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.316B 0.00
CytomX Therapeutics (CTMX) United States $0.310B 0.00
Innate Pharma S.A (IPHA) France $0.295B 0.00
Precision BioSciences (DTIL) United States $0.285B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.283B 0.00
OSMOTICA PHARM (OSMT) United States $0.275B 0.00
Selecta Biosciences (SELB) United States $0.274B 0.00
Cardiff Oncology (CRDF) United States $0.272B 0.00
Cyclerion Therapeutics (CYCN) United States $0.269B 0.00
Prometic Life Sciences (LMNL) Canada $0.268B 0.00
Affimed (AFMD) Germany $0.267B 0.00
ChromaDex (CDXC) United States $0.261B 0.00
Arbutus Biopharma (ABUS) United States $0.251B 0.00
Pluristem Therapeutics (PSTI) Israel $0.248B 0.00
NextCure (NXTC) United States $0.244B 0.00
TELA Bio (TELA) United States $0.229B 0.00
Verastem (VSTM) United States $0.220B 0.00
Dyadic (DYAI) United States $0.210B 0.00
HOOKIPA Pharma (HOOK) United States $0.208B 0.00
Spero Therapeutics (SPRO) United States $0.206B 0.00
XOMA (XOMA) United States $0.204B 0.00
Aduro Biotech (ADRO) United States $0.204B 0.00
Liquidia Technologies (LQDA) United States $0.197B 0.00
DBV Technologies S.A (DBVT) France $0.196B 0.00
Kindred Biosciences (KIN) United States $0.194B 0.00
ADMA Biologics Inc (ADMA) United States $0.193B 0.00
Checkpoint Therapeutics (CKPT) United States $0.192B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Biofrontera AG (BFRA) Germany $0.186B 0.00
Cerecor (CERC) United States $0.185B 0.00
Theratechnologies (THTX) Canada $0.179B 0.00
Eton Pharmaceuticals (ETON) United States $0.179B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.174B 0.00
CorMedix Inc (CRMD) United States $0.169B 0.00
Exicure (XCUR) United States $0.167B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.165B 7.70
SESEN BIO, INC (SESN) United States $0.164B 0.00
Abeona Therapeutics (ABEO) United States $0.163B 0.00
Aptinyx (APTX) United States $0.161B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.157B 0.00
Aytu Bioscience (AYTU) United States $0.157B 0.00
AquaBounty Technologies (AQB) United States $0.150B 0.00
GENFIT S.A (GNFT) France $0.149B 0.00
Nicox SA (NICXF) France $0.149B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.145B 0.00
Five Prime Therapeutics (FPRX) United States $0.141B 0.00
VolitionRX (VNRX) United States $0.141B 0.00
Bellus Health (BLU) Canada $0.138B 0.00
Applied Genetic Technologies (AGTC) United States $0.133B 0.00
VTv Therapeutics (VTVT) United States $0.133B 0.00
Cidara Therapeutics (CDTX) United States $0.131B 0.00
Celyad SA (CYAD) Belgium $0.129B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.124B 0.00
Strongbridge Biopharma (SBBP) United States $0.120B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.117B 0.00
Windtree Therapeutics (WINT) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.117B 0.00
Palatin Technologies (PTN) United States $0.116B 2.99
Lumos Pharma (LUMO) United States $0.115B 0.00
Gritstone Oncology (GRTS) United States $0.111B 0.00
Orgenesis (ORGS) United States $0.111B 5.64
Enzo Biochem (ENZ) United States $0.109B 0.00
Unum Therapeutics (UMRX) United States $0.105B 0.00
Antibe Therapeutics (ATBPF) Canada $0.102B 0.00
PHASEBIO PHARMA (PHAS) United States $0.100B 0.00
Catalyst Biosciences (CBIO) United States $0.098B 0.00
ARAVIVE, INC (ARAV) United States $0.090B 0.00
Evogene (EVGN) Israel $0.089B 0.00
Bionano Genomics (BNGO) United States $0.089B 0.00
Oncobiologics (OTLK) United States $0.087B 0.00
Idera Pharmaceuticals (IDRA) United States $0.087B 0.00
AIT Therapeutics (XAIR) United States $0.087B 0.00
DiaMedica Therapeutics (DMAC) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Ecology Coatings (ABVC) United States $0.076B 0.00
Clearside Biomedical (CLSD) United States $0.074B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.072B 0.00
Prima BioMed (IMMP) Australia $0.071B 0.00
Edesa Biotech (EDSA) Canada $0.071B 0.00
Synlogic (SYBX) United States $0.070B 0.00
TRACON Pharmaceuticals (TCON) United States $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.064B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.062B 0.00
Curis (CRIS) United States $0.060B 0.00
Proteostasis Therapeutics (PTI) United States $0.060B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.059B 0.00
AmpliPhi Biosciences (ARMP) United States $0.058B 0.00
Soligenix (SNGX) United States $0.058B 0.00
Emmaus Life Sciences (EMMA) United States $0.057B 0.00
Cocrystal Pharma (COCP) United States $0.055B 0.00
AnPac Bio-Medical Science (ANPC) China $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.053B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
Stealth BioTherapeutics (MITO) United States $0.051B 72.50
Happiness Biotech Group (HAPP) China $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Novogen (KZIA) Australia $0.049B 0.00
Genetic Technologies (GENE) Australia $0.048B 0.00
CollPlant Holdings (CLGN) Israel $0.047B 0.00
Vaccinex (VCNX) United States $0.047B 0.00
Signal Genetics (MGEN) United States $0.046B 0.00
Organovo Holdings (ONVO) United States $0.045B 0.00
IMMURON (IMRN) Australia $0.044B 0.00
Pulmatrix (PULM) United States $0.040B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Chanticleer Holdings (SONN) United States $0.035B 0.00
Prana Biotechnology (ATHE) Australia $0.033B 0.00
BioCardia (BCDA) United States $0.031B 0.00
OvaScience (MLND) United States $0.031B 0.00
Advaxis (ADXS) United States $0.028B 0.00
Apricus Biosciences (SEEL) United States $0.028B 0.00
Cleveland BioLabs (CBLI) United States $0.027B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Celsion (CLSN) United States $0.026B 0.00
Acorda Therapeutics (ACOR) United States $0.025B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.024B 0.00
Cesca Therapeutics (THMO) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
Spherix (AIKI) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
MYOS RENS Technology (MYOS) United States $0.017B 0.00
BioPharmX (TMBR) United States $0.011B 0.00
Neuralstem (SNCA) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00